2-Diphenylmethylspiro (1,3-oxathiolane-5,3') quinuclidine | 107220-30-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 2-Diphenylmethylspiro (1,3-oxathiolane-5,3') quinuclidine
• 英文别名: 2-Diphenylmethylspiro(1,3-oxathiolane-5,3')-quinuclidine；2-diphenylmethylspiro(1,3-oxathiolane-5,3')quinuclidine；2-Benzhydrylspiro[1,3-oxathiolane-5,3'-1-azabicyclo[2.2.2]octane]
• CAS: 107220-30-4
• 化学式: C₂₂H₂₅NOS
• 分子量: 351.513
• InChiKey: RNALVQQOJDEYFV-UHFFFAOYSA-N

物化性质

• 沸点：
  500.2±50.0 °C(Predicted)
• 密度：
  1.22±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  4.5
• 重原子数：
  25
• 可旋转键数：
  3
• 环数：
  6.0
• sp3杂化的碳原子比例：
  0.45
• 拓扑面积：
  37.8
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  盐酸 、 3-(疏基甲基)-1-阿杂环[2.2.2]辛烷-3-醇 、 联苯乙醛 在 sodium hydroxide 、 trifluoroborane diethyl ether 作用下， 以 二氯甲烷 、 Petroleum ether 为溶剂， 生成 2-Diphenylmethylspiro (1,3-oxathiolane-5,3') quinuclidine
  参考文献：
  名称：

  Derivatives of quinuclidine

  摘要：

  具有一般式（I）的奎尼克啶衍生物##STR1##及其几何异构体、对映异构体、二对映异构体、混合物和/或酸加成盐，其中Z代表>CR.sup.1 R.sup.2基团或两个氢原子；R.sup.1和R.sup.2可以相同也可以不同，分别为烷基、环戊基、环己基、芳基、二苯甲醇基或被一个或多个芳基基团取代的烷基，或者R.sup.1和R.sup.2中的一个可以是氢。

  公开号：

  US04855290A1

文献信息

• Spirooxathiolane-quinuclidine derivative, for treating Sjoegren syndrome
  申请人：SNOW BRAND MILK PRODUCTS CO., LTD.

  公开号：EP0578511A1

  公开（公告）日：1994-01-12

  A composition for treating Sjoegren syndrome disease is disclosed. The composition comprises derivative of spirooxathiolane-quinuclidine of the following formula (I), wherein Z is =CR¹R², wherein R¹ and R² may be the same or different and each represents hydrogen, alkyl, cyclopentyl, cyclohexyl, aryl, diarylmethylol, or alkyl which may be substituted by one or more aryl groups, or an acid addition salt thereof. Especially effective is an administration of a hydrochloric acid addition salt of 2-methylspiro(1,3-oxathiolane-5,3')quinuclidine.

  本发明公开了一种用于治疗斯乔格伦综合征疾病的组合物。该组合物包括下式(I)的螺环氧乙烷-奎宁环衍生物、 其中 Z 为 =CR¹R²，其中 R¹ 和 R² 可以相同或不同，且各自代表氢、烷基、环戊基、环己基、芳基、二芳基甲醇或可被一个或多个芳基取代的烷基，或其酸加成盐。 特别有效的是 2-甲基螺(1,3-氧硫杂环戊烷-5,3')喹吖啶的盐酸加成盐。
• Spirooxathiolane-quinuclidine derivative for the treatment of xerostomia
  申请人：SNOW BRAND MILK PRODUCTS CO., LTD.

  公开号：EP0689836A1

  公开（公告）日：1996-01-03

  A therapeutic agent for the treatment of xerostomia comprises a derivative of spirooxathiolane-quinuclidine or an acid addition salt thereof as an active ingredient represented by the following formula [I]: (wherein R¹ and R may be the same or different and each represents hydrogen, alkyl, cyclopentyl, cyclohexyl, aryl, diarylmethylol, or alkyl which may be substituted by one or more aryl groups). The above therapeutic agent can be administered orally or parentally and cure xerostomia. Specifically, the agent can be used for improving and/or curing dry mouth caused by various diseases with organic changes in salivary gland, lesions in salivary gland accompanied with systemic diseases, necrosis of salivary gland cell by radiotherapy, HIV infection (AIDS), hypo-function of saliva secretion, affection of various medicines taken and, further, mental fatigue or bad conditions due to complex social life situations.

  一种用于治疗口腔干燥症的治疗剂包括螺环硫醇喹吖啶衍生物或其酸性加成盐，作为下式[I]所代表的活性成分： (其中R¹和R可以相同或不同，各自代表氢、烷基、环戊基、环己基、芳基、二芳基甲醇或可被一个或多个芳基取代的烷基）。 上述治疗剂可以口服或亲代给药，治疗口腔干燥症。具体而言，本制剂可用于改善和/或治疗因唾液腺器质性病变的各种疾病、唾液腺病变并伴有全身性疾病、放疗导致的唾液腺细胞坏死、艾滋病毒感染（艾滋病）、唾液分泌功能低下、服用的各种药物的影响以及复杂的社会生活环境导致的精神疲劳或不良状况引起的口干。
• Agent For Oral Mucosal Administration
  申请人：Nakajima Noriko

  公开号：US20110150974A1

  公开（公告）日：2011-06-23

  A medicament used for prophylactic and/or therapeutic treatment of xerostomia, which is in the form for oral mucosal administration comprising a spirooxathiolane quinuclidine derivative represented by the following general formula (I) or an acid addition salt thereof: [Formula 1] (wherein R 1 and R 2 may be the same or different, and independently represent a hydrogen atom, an alkyl group, a cyclopentyl group, a cyclohexyl group, a monoaryl- or diaryl-substituted methylol group, or an aryl-substituted alkyl group) as an active ingredient.
• US4855290A
  申请人：——

  公开号：US4855290A

  公开（公告）日：1989-08-08
• US5340821A
  申请人：——

  公开号：US5340821A

  公开（公告）日：1994-08-23